US 10226535
Auristatin compounds and conjugates thereof
granted A61KA61K47/59
Quick answer
US patent 10226535 (Auristatin compounds and conjugates thereof) held by Mersana Therapeutics, Inc. expires Mon Mar 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Mersana Therapeutics, Inc.
- Grant date
- Tue Mar 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K47/59